Veranstaltung Ansichten-Navigation


What is Enough… Women in Clinical Trials?


On May 16, 2018 from 1:00 pm - 2:30 pm (Eastern Daylight Time EDT), join the FDA Office of Women’s Health for The Great Debate! Featuring Ellis F. Unger, M.D., FDA CDER, and Rita F. Redberg, M.D., M.Sc., F.A.C.C. The debate centers on cardiovascular disease clinical trials and the challenges and complexity of the question […]

Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender

FDA White Oak Campus, Bldg. 31, Great Room

Sex differences may influence susceptibility to substance use disorders, which could have implications for optimal prevention and treatment. Gender influences also impact public health by influencing  rescription rates, care, and treatment-seeking behaviors. To identify and treat at-risk women, researchers, educators, and clinicians must be able to recognize and consider sex and gender differences in substance […]

BIH Excellence Award

Berlin Institute of Health Excellence Award for Sex and Gender Aspects in Health Research Apply until June 30, 2019! For the second time the Berlin Institute of Health announces the “BIH Excellence Award for Sex and Gender Aspects in Health Research”. The award aims to bring more visibility to sex and gender issues in translational […]

IGM Kongress 2022

Padua, Italien

10th Congress of the international Society of Gender Medicine Main Topics: Epidemiology Oncology Basic and translational Sciences Neurology Pharmacology Metabolic Diseases Paediatrics Transgender Health Aging/Geriatrics Diversity & Inclusion: care for everyone Covid-19 Pandemic Life styles Cardiovascular Diseases Public Health Artificial Intelligence Social and psychological Sciences Infectious Diseases and Vaccines Education and Communication Strategies Immunology Environmental […]